eMedicine Specialties > Plastic Surgery > Skin

Skin Resurfacing, Carbon Dioxide Laser: Treatment

Author: Andrew Jacono, MD, Chief, Section of Facial Plastic and Reconstructive Surgery, The North Shore University Hospital at Manhasset; Assistant Professor, Division of Facial Plastic Surgery, The New York Eye and Ear Infirmary, New York Medical College; Assistant Professor, Department of Head and Neck Surgery, Albert Einstein College of Medicine; Director, The New York Center for Facial Plastic and Laser Surgery
Coauthor(s): William A Kennedy III, MD, Fellow, Facial Plastic and Reconstructive Surgery, New York Center for Facial Plastic Surgery, Albert Einstein College of Medicine; Michael B Stevens, MD, PhD, Consulting Staff, Department of Plastic Surgery, Kaweah Delta Hospital
Contributor Information and Disclosures

Updated: Nov 13, 2009

Treatment

Preoperative Details

Selecting a suitable patient for carbon dioxide laser resurfacing is essential to achieve the desired results. Pay specific attention to skin type and degree of photodamage.

  • At least 6 weeks before carbon dioxide laser skin resurfacing, start all patients on a daily skin conditioning regimen, which consists of the following medications:
    • Retinoic acid 0.05-0.1% cream (0.5-1 g Retin-A) in evening
    • Hydroquinone 2-4% cream (0.5-1 g Clear or Eldoquin Forte) twice per day, in morning and evening (author does not necessarily use hydroquinone on patients who are light white [Fitzpatrick phototype 1])
    • Alpha-hydroxy acid 2-4% cream (0.5-1 g Exfoderm) in morning
    • Sun protection (SPF 15 or higher, Sunfader or sunblock) applied in morning
  • Patients should wash their faces with an antibacterial soap the night and morning prior to laser treatment.

Intraoperative Details

  • Observe laser safety at all times.
    • Carbon dioxide laser light can cause a fire. No flammable objects should be present in laser field (eg, dry hair, dry gauze, alcohol).
    • Supplemental nasal cannula oxygen must be turned off during laser resurfacing.
    • Proper eye protection for patient, physician, and assistants is mandatory.
    • Use proper evacuation of vaporized tissue plume to reduce chance of airborne transmitted diseases.
  • Clean patient's face with antibacterial soap. If isopropyl alcohol or acetone is used, understand that these agents are flammable and take precautions. Chlorhexidine gluconate (Hibiclens) and hexachlorophene detergent cleanser (PHisoHex) can cause keratitis.
  • Coat metal eye shields with sterile ophthalmic petrolatum to reduce chance of corneal abrasion.
  • Cover periphery of face with wet cloths.
  • Protecting teeth with wet gauze under lips reduces chance of enamel damage.

Anesthesia choices

  • Topical anesthetics (eg, eutectic mixture of lidocaine/prilocaine [EMLA]) and local infiltration with lidocaine or tumescent anesthesia often does not lead to complete anesthesia, may distort existing wrinkles or scars, and may change laser-tissue optomechanical properties.
  • Regional nerve block combined with intravenous (IV) conscious sedation seems to be the preferred method of anesthesia among laser surgeons. Fourteen nerve blocks are required: supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticofacial, mental, and cervical plexus.
  • IV sedation using propofol (Diprivan) is rapid and easily titrated. Midazolam (Versed) provides initial sedation as well as amnesia. Fentanyl (Sublimaze) is the primary analgesia, although some anesthesiologists also use ketamine. IV sedation requires the presence of an anesthesiologist, oxygen source, electrocardiogram and blood pressure monitors, pulse oximeter, IV access, and resuscitation cart.
  • Laryngeal mask airway combined with IV sedation and general anesthesia with endotracheal intubation are other acceptable methods of anesthesia. Cover endotracheal and laryngeal mask airway tubes with wet towels.

Carbon dioxide laser resurfacing technique

  • Treatment parameters are set according to carbon dioxide laser device and are individualized for each patient according to the condition treated, skin type, and goal to be achieved.
  • By achieving tissue vaporization in a single laser pulse, vapor that is created absorbs most of the heat generated, with resultant minimal diffusion of heat into the skin.
  • Pulse stacking leads to cumulative thermal injury in the skin.
  • When using a single spot hand piece, move it across the skin carefully and activate the laser at a slow enough rate (4-10 Hz) to deliver single pulses with minimal overlap of subsequent pulses.
  • Avoid overlap of the edges of computerized pattern generator patterns.
  • Generally, the first laser pass results in the removal of the epidermis, leaving behind a narrow zone of thermal damage (10-30 µm). Skin appears white with desiccated debris composed of epidermal tissue remaining after water evaporation.
  • After the first pass, rehydrate skin with moist saline-soaked gauze, remove debris using gentle rubbing, then wipe treated area using dry gauze.
  • Perform second pass in the same manner as the first pass; however, pulses may be oriented at 90° to the direction used for the first pass.
  • In general, a third pass or subsequent passes can be applied more selectively to areas of advanced photodamage or scarring (shoulder of acne scars), often using a single spot handpiece.
  • Relationship between number of laser passes and tissue ablation/thermal damage is not linear.
  • The first laser pass significantly ablates more tissue than the second or subsequent passes; an ablation plateau is reached in 3-4 passes, limiting ablation depth to approximately 250 µm. However, thermal damage is cumulative with each additional laser pass, resulting in a wider zone of necrosis.
  • Perform laser resurfacing in a systematic fashion, beginning on the forehead and proceeding down the remainder of the face. Eyelid resurfacing often is performed last because eyelids are treated at lower pulse settings and densities and require additional care to avoid burning the eyelashes.
  • Resurfacing of a single area alone generally is not advised to avoid sharp demarcations. One alternative is to perform carbon dioxide laser resurfacing on the desired area, then treat surrounding nonresurfaced areas with a less aggressive procedure such as the blue peel (15-20% trichloroacetic acid [TCA] in a blue base).6,7
  • Perform feathering of margin between resurfaced and nonresurfaced skin edges to prevent demarcation lines. Treating the band of skin between the resurfaced and nonresurfaced skin at lower fluences accomplishes the desired blending. Feathering into the hairline and jawline also can reduce demarcation lines.
  • Laser resurfacing endpoints are as follows:
    • As with any resurfacing modality, depth control is essential in carbon dioxide laser skin resurfacing to avoid potential complications and obtain best results.
    • Confine depth to the papillary dermis or upper reticular/midreticular dermis.
    • In general, as depth of penetration increases, risk of textural changes, scarring, and permanent hypopigmentation or depigmentation increases.
    • Cosmetic endpoint is the ablation of the target (eg, scar, wrinkle).
    • Safety endpoint is the appearance of a "chamois" yellow skin color that persists after wiping with a saline-soaked gauze, even if treated lesion persists.

Postoperative Details

  • Oral antibiotics (eg, cephalexin [Keflex]), antiviral medications (eg, acyclovir [Zovirax]), and oral analgesics (eg, ibuprofen [Motrin]) are prescribed routinely.
  • Some laser surgeons use oral anti-inflammatory medications (eg, nonsteroidal anti-inflammatory medications) or corticosteroids to manage postoperative swelling.
  • Oral anxiolytics (eg, lorazepam [Ativan], diazepam [Valium]) are helpful to relieve anxiety and improve sleep patterns.
  • Oral antipruritic (eg, hydroxyzine [Atarax]) medications are administered as needed.
  • Remind patients to avoid picking at their skin and to avoid rubbing skin vigorously when cleaning it or while in the shower.
  • Dressings are used as follows:
    • Care for the skin after laser resurfacing is similar to managing a second-degree thermal burn.
    • Keeping the wound moist promotes faster reepithelialization.
    • In general, 2 methods of wound dressing exist.
      • Open technique: Apply an occlusive ointment (eg, petrolatum) to the resurfaced areas until reepithelialization is complete. Avoid use of topical antibiotics (eg, bacitracin [Polysporin]) because of increased risk of contact dermatitis. Advantages include its low cost, decreased rate of infections, use by patients at home, and suitability for regional resurfacing. Disadvantages are that it is more painful, it is messy, and it requires patient compliance.
      • Closed technique: Apply semiocclusive biosynthetic dressing until reepithelialization is almost complete. A wide variety of these dressings are available, including polyurethane films (Silon II), hydrocolloids (Flexzan), and hydrogels (Vigilon). Advantages include that it is painless and faster healing occurs. Disadvantages are the increased cost, increased rate of infection, and need for frequent office visits.

Follow-up

  • Closely monitor patients during the postoperative period. Have frequent follow-up visits at close intervals with patients to provide much needed support and to detect complications early in the course.
  • Recovery for full face laser resurfacing is 7-14 days depending mainly on depth achieved.
  • During the first week, the patient experiences variable degrees of oozing and crusting depending on the dressing used.
  • Apply dressings until complete reepithelialization takes place. Patient then can start applying a light water-based moisturizer for the next 2-3 weeks.
  • Begin postprocedure skin reconditioning early during the healing process. Reintroduce hydroquinone and retinoic acid 3-4 weeks postoperatively. Avoid alpha-hydroxy acids until stratum corneum is regenerated fully and skin tolerance has returned. Use sunscreens once reepithelialization occurs.
  • Evaluate patient at 2-3 days, 1 week, 3-4 weeks, 3 months, 6 months, and 1 year postresurfacing.

Complications

Similar to other resurfacing modalities, incidence of complications following carbon dioxide laser resurfacing primarily is related to depth attained.

Expected sequelae commonly are encountered after carbon dioxide laser resurfacing and must be clearly differentiated from true complications.8

Sequelae

  • Swelling: Postresurfacing swelling is expected. It peaks at days 2-3 and usually subsides by days 5-7. IV betamethasone intraoperatively and a course of oral prednisone postoperatively for 5 days can help significantly in decreasing the swelling.
  • Erythema
    • Erythema, to some degree, is observed in all patients who have been resurfaced to the level of the upper dermis with the carbon dioxide laser.
    • It is related to increased blood flow, collagen remodeling, inflammation, and increased metabolic activity.
    • Erythema is more obvious in patients with lighter skin complexion and in patients with flushing or blushing tendencies (eg, those with acne rosacea).
    • While erythema is usually transient, it may persist for weeks to months, yet it generally can be camouflaged with green-tinted or yellow-tinted makeup.
    • Do not use topical steroids to treat postresurfacing erythema since they reduce collagen synthesis.
    • Carbon dioxide lasers that do not induce erythema have produced only superficial injury, and the procedure does not induce collagen remodeling.
    • Differentiate diffuse erythema of laser resurfacing from focal, itchy, palpable, or persistent erythema that is a sign of developing hypertrophic scar or keloid.
  • Itching (pruritus): Itching is common after laser resurfacing, yet it may signal infection, contact dermatitis, or early scarring. In the absence of these conditions, pruritus responds to an oral antihistamine or midpotency topical steroid (eg, mometasone furoate 0.1% [Elocon]).
  • Acne flare/milia: Milia and acne commonly are observed 2-4 weeks after carbon dioxide laser resurfacing and partially are related to the use of occlusive ointments. Many of these patients are acne prone at the start, and their condition can be improved significantly by reintroducing retinoic acid and topical antibiotics to their postresurfacing regimen. Additionally, a 2- to 3-month course of oral antibiotics (eg, tetracycline [Achromycin V]) or oral isotretinoin (Accutane) usually is very helpful. Comedones and milia can be expressed manually using a comedone extractor.
  • Postresurfacing hyperpigmentation
    • Hyperpigmentation after resurfacing is common, especially in patients with dark skin.
    • It usually first is observed 14-21 days after the procedure and represents a postinflammatory hyperpigmentation phenomenon.
    • Preconditioning the skin with retinoic acid and hydroquinone prior to carbon dioxide resurfacing decreases incidence, severity, and duration of hyperpigmentation. Resulting hyperpigmentation also may be more amenable to therapy.
    • Aggressive postresurfacing skin reconditioning using hydroquinone 2-4% twice per day, retinoic acid (0.5-0.1%) every bedtime, and sun protection and sunscreen resolves this condition in 2-4 weeks.

True complications

  • Infection (bacterial, viral, yeast, fungal)
    • Typical presentation is a papulopustular eruption with itching or pain and delayed healing.
    • Occasionally, infection presents as maceration and necrotic tissue in a previously healed area.
    • Culture lesions using the appropriate medium (viral, bacterial, fungal).
    • Begin appropriate topical and systemic medications as soon as possible.
  • Contact dermatitis
    • Irritant or allergic contact dermatitis can occur secondary to topical antibiotics (eg, neomycin, bacitracin).
    • Dermatitis can be treated successfully with potent topical corticosteroids (eg, clobetasol propionate 0.05% [Temovate]).
    • Systemic steroids rarely are needed.
  • Hypopigmentation9
    • Occurrence of hypopigmentation certainly is related to depth of resurfacing and resultant thermal injury.
    • It usually occurs in lighter skin types (Fitzpatrick phototypes 1-3) and is observed 6-12 months postresurfacing.

    • Depigmentation periorbitally, periorally, and on ...

      Depigmentation periorbitally, periorally, and on the forehead following carbon dioxide laser resurfacing.

      Depigmentation periorbitally, periorally, and on ...

      Depigmentation periorbitally, periorally, and on the forehead following carbon dioxide laser resurfacing.

    • This complication can be avoided by performing the following:
      • Avoid regional resurfacing (especially in individuals with darker skin); instead, perform full face resurfacing.
      • Limit resurfacing depth to the papillary dermis or upper reticular dermis.
      • Stimulate skin to regenerate pigment in the epidermis by recruiting melanocytes in the adnexal structures. This can be attempted by using retinoic acid nightly.
  • Sharp demarcation lines: Avoid these by creating a transitional zone of resurfaced skin (ie, gradual change in depth of resurfacing between face and neck) and combining full face resurfacing with a light chemical peel such as the blue peel on the neck to create a less noticeable gradient zone between resurfaced face and neck/chest.
  • Hypertrophic scars and keloids
    • Development of scars is mainly related to (1) depth of resurfacing achieved, (2) development of infection, (3) postoperative wound care, and (4) other patient-related factors (eg, excoriations).
    • It is observed more commonly in nonfacial skin resurfacing.3
    • Localized persistent erythema with or without pruritus should be considered an evolving hypertrophic scar until proven otherwise.
    • Aggressively treat with high-potency topical steroids (eg, clobetasol propionate 0.05% [Temovate]), intralesional steroids (eg, triamcinolone acetonide 10 mg/mL [Aristocort]), 5-fluorouracil, or verapamil. Silicone gel sheeting and pulsed dye laser therapy are very helpful.
  • Ectropion and scleral show
    • Ectropion usually is related to aggressive carbon dioxide laser resurfacing of the lower eyelids, preexisting laxity of the lower lids, previous skin excision during blepharoplasty, or development of an infection.
    • It can be avoided by testing lid for laxity before resurfacing, by limiting depth of resurfacing on the eyelids to the papillary dermis, and by decreasing power settings.
    • Use of eye lubricants to prevent drying, upwardly massaging lower eyelid 3-4 times per day, and using a potent steroid cream are helpful measures.
    • In extreme cases a skin graft may be required.
  • Tooth enamel injury: This can be avoided by proper teeth protection.
  • Corneal abrasion/injury: This can be avoided by using the patient's eye shields properly, placing particular emphasis on choosing the correct size, and applying copious eye lubricants prior to inserting metal shields.

More on Skin Resurfacing, Carbon Dioxide Laser

Overview: Skin Resurfacing, Carbon Dioxide Laser
Treatment: Skin Resurfacing, Carbon Dioxide Laser
Follow-up: Skin Resurfacing, Carbon Dioxide Laser
Multimedia: Skin Resurfacing, Carbon Dioxide Laser
References

References

  1. Ross EV, Domankevitz Y, Skrobal M, Anderson RR. Effects of CO2 laser pulse duration in ablation and residual thermal damage: implications for skin resurfacing. Lasers Surg Med. 1996;19(2):123-9. [Medline].

  2. Horton S, Alster TS. Preoperative and postoperative considerations for carbon dioxide laser resurfacing. Cutis. Dec 1999;64(6):399-406. [Medline].

  3. Avram MM, Tope WD, Yu T, Szachowicz E, Nelson JS. Hypertrophic scarring of the neck following ablative fractional carbon dioxide laser resurfacing. Lasers Surg Med. Mar 2009;41(3):185-8. [Medline].

  4. Sandel HD 4th, Perkins SW. CO2 laser resurfacing: still a good treatment. Aesthet Surg J. Jul-Aug/ 2008;28(4):456-62. [Medline][Full Text].

  5. Avram MM, Tope WD, Yu T, Szachowicz E, Nelson JS. Hypertrophic scarring of the neck following ablative fractional carbon dioxide laser resurfacing. Lasers Surg Med. 03/2009;41(3):185-188. [Medline][Full Text].

  6. Obagi ZE, Obagi S, Alaiti S, Stevens MB. TCA-based blue peel: a standardized procedure with depth control. Dermatol Surg. Oct 1999;25(10):773-80. [Medline].

  7. Sandel HD 4th, Perkins SW. CO2 laser resurfacing: still a good treatment. Aesthet Surg J. Jul-Aug 2008;28(4):456-62. [Medline].

  8. Fife DJ, Fitzpatrick RE, Zachary CB. Complications of fractional CO2 laser resurfacing: four cases. Lasers Surg Med. 03/2009;41(3):179-84. [Medline][Full Text].

  9. Ward PD, Baker SR. Long-term results of carbon dioxide laser resurfacing of the face. Arch Facial Plast Surg. Jul-Aug 2008;10(4):238-43; discussion 244-5. [Medline].

  10. Chajchir A, Benzaquen I. Carbon dioxide laser resurfacing with fast recovery. Aesthetic Plast Surg. 2005;29:107-12. [Medline].

  11. Chernoff WG, Cramer H. Rejuvenation of the skin surface: laser exfoliation. Facial Plast Surg. Apr 1996;12(2):135-45. [Medline].

  12. Fulton JE, Rahimi AD, Helton P, Dahlberg K. Neck rejuvenation by combining Jessner/TCA peel, dermasanding, and CO2 laser resurfacing. Dermatol Surg. Oct 1999;25(10):745-50. [Medline].

  13. Hruza GJ, Dover JS. Laser skin resurfacing [editorial; comment]. Arch Dermatol. Apr 1996;132(4):451-5. [Medline].

  14. Kilmer SL. Laser resurfacing complications: How to treat them and how to avoid them. Int J Aesth Restor Surg. 1997;5:1:41-45.

  15. Stevens MB. Laser resurfacing and combined procedures. In: Obagi Skin Health Restoration and Rejuvenation. Vol 1. 1999:247-283.

  16. Trelles MA, Brychta P, Stanek J,. Laser techniques associated with facial aesthetic and reparative surgery. Facial Plast Surgery. 2005;21:83-98. [Medline].

  17. Walia S, Alster TS. Cutaneous CO2 laser resurfacing infection rate with and without prophylactic antibiotics. Dermatol Surg. Nov 1999;25(11):857-61. [Medline].

  18. Ziering CL. Cutaneous laser resurfacing with the Erbium YAG laser and the char-free carbon dioxide laser. A clinical comparison of 100 patients. Int J Aesth Restor Surg. 1997;5:1:29-37.

Further Reading

Keywords

laser skin resurfacing, cutaneous laser resurfacing, carbon dioxide laser, CO2 laser, CO2 laser, aging, photoaged skin, chemical peeling agents, thermal damage, rhytids, wrinkles

Contributor Information and Disclosures

Author

Andrew Jacono, MD, Chief, Section of Facial Plastic and Reconstructive Surgery, The North Shore University Hospital at Manhasset; Assistant Professor, Division of Facial Plastic Surgery, The New York Eye and Ear Infirmary, New York Medical College; Assistant Professor, Department of Head and Neck Surgery, Albert Einstein College of Medicine; Director, The New York Center for Facial Plastic and Laser Surgery
Andrew Jacono, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, and American Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

William A Kennedy III, MD, Fellow, Facial Plastic and Reconstructive Surgery, New York Center for Facial Plastic Surgery, Albert Einstein College of Medicine
William A Kennedy III, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery and American Academy of Otolaryngology-Head and Neck Surgery
Disclosure: Nothing to disclose.

Michael B Stevens, MD, PhD, Consulting Staff, Department of Plastic Surgery, Kaweah Delta Hospital
Michael B Stevens, MD, PhD is a member of the following medical societies: American College of Surgeons, California Medical Association, Lipoplasty Society of North America, and Lipoplasty Society of North America
Disclosure: Nothing to disclose.

Medical Editor

Tolbert Wilkinson, MD, Consulting Staff, Department of Surgery, Southwest Texas Methodist Hospital
Tolbert Wilkinson, MD is a member of the following medical societies: American College of Surgeons, American Society for Aesthetic Plastic Surgery, Phi Beta Kappa, and Texas Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Wayne Karl Stadelmann, MD, Stadelmann Plastic Surgery, PC
Wayne Karl Stadelmann, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, American Society of Plastic Surgeons, New Hampshire Medical Society, Northeastern Society of Plastic Surgeons, and Phi Beta Kappa
Disclosure: Nothing to disclose.

CME Editor

Nicolas (Nick) G Slenkovich, MD, Director, Colorado Plastic Surgery Center
Nicolas (Nick) G Slenkovich, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Society of Aesthetic Plastic Surgery, American Society of Plastic Surgeons, and Colorado Medical Society
Disclosure: Nothing to disclose.

Chief Editor

Gregory Caputy, MD, PhD, FICS, Chief Surgeon, Aesthetica Plastic and Laser Surgery Center, Inc
Gregory Caputy, MD, PhD, FICS is a member of the following medical societies: American Society for Laser Medicine and Surgery, Canadian Medical Association, International College of Surgeons, International College of Surgeons US Section, Pan-Pacific Surgical Association, and Wound Healing Society
Disclosure: Syneron Corporation Salary Speaking and teaching

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.